Cutting-edge treatment approach addresses neurobehavioral symptoms in neurofibromatosis type 1

Updated on: August 07,2025

Cutting-edge treatment approach addresses neurobehavioral symptoms in neurofibromatosis type 1

Updated on:August 07,2025

Could 'zombie cells' in the skin be aging your brain too?

by Mayo Clinic News NetworkCredit: Pixabay/CC0 Public DomainMayo Clinic researchers have found that senescent cells—non-dividing "zombie" cells—accumulate in the skin as people age and may i

Updated on: November 06,2024

Could 'zombie cells' in the skin be aging your brain too?

by Mayo Clinic News NetworkCredit: Pixabay/CC0 Public DomainMayo Clinic researchers have found that senescent cells—non-dividing "zombie" cells—accumulate in the skin as people age and may i

Updated on:November 06,2024

Researchers discover mechanism by which estrogen can trigger fast neuronal responses

byBaylor College of MedicineCredit: Public DomainEstrogen, the major female ovarian hormone, can trigger nerve impulses within milliseconds to regulate a variety of physiological processes. At B

Updated on: October 14,2024

Researchers discover mechanism by which estrogen can trigger fast neuronal responses

byBaylor College of MedicineCredit: Public DomainEstrogen, the major female ovarian hormone, can trigger nerve impulses within milliseconds to regulate a variety of physiological processes. At B

Updated on:October 14,2024

Alzheimer's disease can be diagnosed before symptoms emerge

by Lund UniversityNIA-AA versus IWG criteria. Differences in the nomenclature of cognitively unimpaired individuals with (+) or without (−) in vivo biomarker evidence of Aβ (A) and tau (T) pathol

Updated on: April 10,2024

Alzheimer's disease can be diagnosed before symptoms emerge

by Lund UniversityNIA-AA versus IWG criteria. Differences in the nomenclature of cognitively unimpaired individuals with (+) or without (−) in vivo biomarker evidence of Aβ (A) and tau (T) pathol

Updated on:April 10,2024

New discovery could help treat a rare and severe form of amyloidosis

byWileyPET scan of a human brain with Alzheimer's disease. Credit: public domainIn people with a rare condition called light chain amyloidosis, light chain proteins—which are a component of

Updated on: July 11,2024

New discovery could help treat a rare and severe form of amyloidosis

byWileyPET scan of a human brain with Alzheimer's disease. Credit: public domainIn people with a rare condition called light chain amyloidosis, light chain proteins—which are a component of

Updated on:July 11,2024

Prediction of conversion to Alzheimer's disease with longitudinal measures and time-to-event data

by IOS PressPredicting the timing of Alzheimer's disease (AD) conversion for individuals with mild cognitive impairment (MCI) can be significantly improved by incorporating longitudinal chang

Updated on: March 07,2024

Prediction of conversion to Alzheimer's disease with longitudinal measures and time-to-event data

by IOS PressPredicting the timing of Alzheimer's disease (AD) conversion for individuals with mild cognitive impairment (MCI) can be significantly improved by incorporating longitudinal chang

Updated on:March 07,2024

Combining cell therapy with approved drug shows promise for treating multiple sclerosis

byJosep Carreras Leukaemia Research InstituteCredit: Pixabay/CC0 Public DomainMultiple sclerosis (MS) is a long-term disease where the immune system mistakenly attacks the protective layer aroun

Updated on: October 14,2024

Combining cell therapy with approved drug shows promise for treating multiple sclerosis

byJosep Carreras Leukaemia Research InstituteCredit: Pixabay/CC0 Public DomainMultiple sclerosis (MS) is a long-term disease where the immune system mistakenly attacks the protective layer aroun

Updated on:October 14,2024

Biogen reanalyzes studies, presses ahead on Alzheimer's drug

by Marilynn MarchioneIn this Aug. 14, 2018 file photo, Dr. William Burke goes over a PET brain scan at Banner Alzheimers Institute in Phoenix. The drug company Biogen Inc. says it will seek federal ap

Updated on: April 25,2024

Biogen reanalyzes studies, presses ahead on Alzheimer's drug

by Marilynn MarchioneIn this Aug. 14, 2018 file photo, Dr. William Burke goes over a PET brain scan at Banner Alzheimers Institute in Phoenix. The drug company Biogen Inc. says it will seek federal ap

Updated on:April 25,2024

Potential noninvasive test for Alzheimer's disease

by University of Central LancashireProfessor Francis Martin, principal investigator of the study and Biosciences theme lead at UCLan. Credit: University of Central LancashireIn the largest and most co

Updated on: April 07,2024

Potential noninvasive test for Alzheimer's disease

by University of Central LancashireProfessor Francis Martin, principal investigator of the study and Biosciences theme lead at UCLan. Credit: University of Central LancashireIn the largest and most co

Updated on:April 07,2024

New synapse type discovered through spatial proteomics

by Tamara Bäßler,Max Planck SocietyNeuronal atlas with 30 different protein types in spatial resolution, visualized with the new SUM-PAINT method. The detailed images illustrate the extremely hi

Updated on: March 30,2024

New synapse type discovered through spatial proteomics

by Tamara Bäßler,Max Planck SocietyNeuronal atlas with 30 different protein types in spatial resolution, visualized with the new SUM-PAINT method. The detailed images illustrate the extremely hi

Updated on:March 30,2024

Experimental drug targeting Alzheimer's disease shows anti-aging effects

by Salk InstituteAs mice age, those treated with J147 (right) showed improved physiology, memory and appearance that more closely resembled younger mice. Credit: Salk Institute for Biological Stu

Updated on: February 27,2024

Experimental drug targeting Alzheimer's disease shows anti-aging effects

by Salk InstituteAs mice age, those treated with J147 (right) showed improved physiology, memory and appearance that more closely resembled younger mice. Credit: Salk Institute for Biological Stu

Updated on:February 27,2024

Comparing the polarimetric properties of fresh and preserved brain tissue

by SPIEWhile preserving brain tissue samples in formalin slightly alters their polarimetric properties, they are still similar to those of fresh samples, making them suitable for training machine

Updated on: February 05,2024

Comparing the polarimetric properties of fresh and preserved brain tissue

by SPIEWhile preserving brain tissue samples in formalin slightly alters their polarimetric properties, they are still similar to those of fresh samples, making them suitable for training machine

Updated on:February 05,2024